client logo
Version: 1.0.0 | Published: 8 Oct 2024 | Updated: 226 days ago

Hospitalised and ventilator acquired pneumonia severity, treatments, outcomes

Dataset

Documentation

Description:
Background: Hospital-Acquired pneumonia (HAP) and Ventilator-Associated pneumonia is an infection of the lungs that is contracted by a patient 2 or more days after an admission. HAP is often more serious than other lung infections due to the nature of the bacteria present in hospital settings, as they are more resistant to treatment than those in the community. HAP typically affects older patients with co-morbidities, those with weakened immune systems or a long-term chronic lung disease. Ventilator-Associated pneumonia is the most common infection associated with a stay in intensive care, with increased long-term mortality and length of stays. These data allow the investigation of the sensitivities of the bacteria, which antibiotics were administered and patient outcomes. The period of data available allows for studying pre- and post- COVID-19 and the impact of ventilation. PIONEER geography: The West Midlands (WM) has a population of 5.9 million and includes a diverse ethnic and socio-economic mix. EHR: UHB is one of the largest NHS Trusts in England, providing direct acute services and specialist care across four hospital sites, with 2.2 million patient episodes per year, 2750 beds and an expanded 250 ITU bed capacity during COVID. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary and secondary care record (Your Care Connected) and a patient portal “My Health”. Scope: All hospitalised patients from 2000 onwards, curated to focus on Hospital and ventilator acquired pneumonia. Longitudinal and individually linked, so that the preceding and subsequent health journey can be mapped and healthcare utilisation prior to and after admission understood. The dataset includes highly granular patient demographics and co-morbidities taken from ICD-10 and SNOMED-CT codes. Serial, structured data pertaining to acute care process (timings, staff grades, specialty review, wards and triage). Along with presenting complaints, outpatients admissions, microbiology results, referrals, procedures, therapies, all physiology readings (pulse, blood pressure, respiratory rate, oxygen saturations and others), and all blood results(urea, albumin, platelets, white blood cells and others). Includes all prescribed and administered treatments and all outcomes. Linked images are also available (radiographs, CT scans, MRI). Available supplementary data: Matched controls; ambulance, OMOP data, synthetic data. Available supplementary support: Analytics, Model build, validation and refinement; A.I.; Data partner support for ETL (extract, transform and load) process, Clinical expertise, Patient and end-user access, Purchaser access, Regulatory requirements, Data-driven trials, “fast screen” services.

Coverage

Spatial:
United Kingdom,England,West Midlands
Typical Age Range:
0-113
Follow Up:
Other
Pathway:
Data is representative of the multi-ethnicity population within the West Midlands (42% non white). Data includes all patients admitted during this timeframe, with National data Opt Outs applied, and therefore is representative of admissions to secondary care. Data focuses on in-patient stay in hospital during the acute episode but can be supplemented on request to include previous and subsequent hospital contacts (including outpatient appointments) and ambulance, 111, 999 data.

Provenance

Origin

Purposes:
Care
Sources:
EPR
Collection Situations:
  • Secondary care - Accident and Emergency
  • Secondary care - In-patients

Temporal

Accrual Periodicity:
Quarterly
Distribution Release Date:
09 March 2022
Start Date:
01 January 2000
End Date:
31 December 2021
Time Lag:
Other

Accessibility

Access

Access Service:
Trusted Research Environments (TRE) are built using Microsoft Azure services and hosted in the UK to provide research teams a safe, secure and agile environment which allows users to quickly analyse, interpret and form an enriched view of primary care information through a range of integrated datasets. Health data collated from multiple sources is ingested into a secure data lake which will then allow subsets of data to be made available to research teams on approval of a data request. Once approved a customer specific TRE is made available with a standard set of leading analytical tools from Microsoft including Azure Databricks, Azure Machine Learning, Azure SQL and Azure Synapse (for large-scale data warehouses). Specific tools can be provided at an additional cost over the standard platform data access charge and the PIONEER team will work with you to determine your exact needs. Access to the TRE is managed using the latest virtual desktop technology to provide a safe and secure end-user experience. By utilising leading edge design PIONEER are able to create TREs rapidly to enable us to service any customer requirement.
Access Request Cost:
www.pioneerdatahub.co.uk/data/data-services-costs/
Delivery Lead Time:
Not applicable
Jurisdictions:
GB-ENG
Data Controller:
University Hospitals Birmingham NHS Foundation Trust

Usage

Data Use Limitations:
General research use
Data Use Requirements:
Project-specific restrictions
Resource Creators:
This publication uses data from PIONEER, an ethically approved database and analytical environment (East Midlands Derby Research Ethics 20/EM/0158)

Format and Standards

Vocabulary Encoding Schemes:
  • SNOMED CT
  • OPCS4
  • ICD10
Conforms To:
LOCAL
Languages:
en
Formats:
SQL

Observations

Statistical Population
Population Description
Population Size
Measured Property
Observation Date
Persons
60,283 patient admissions with Hospital acquired pneumonia between 01-01-2000 and 31-12-2021
60283
Count
09 March 2022